Sionna Therapeutics, Inc.
3.60USD
-0.2000 (-5.26%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SION.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.68▼ | -$0.65 | 2 | 1 |
| Next quarter | -$0.55▲ | -$0.66 | 3 | 0 |
| Current year | -$2.45▲ | -$2.54 | 2 | 1 |
| Next year | -$2.23▲ | -$2.8 | 3 | 0 |
Beat in 2 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.65 | -$0.66 | -0.01 (-2.0%) |
| 2026-03-31 | -$0.5 | -$0.6 | -0.10 (-19.1%) |
| 2025-12-31 | -$0.54 | -$0.46 | +0.08 (+14.0%) |
| 2025-09-30 | -$0.48 | -$0.46 | +0.01 (+3.2%) |
25 ratings from 10 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wedbush | Maintained | Neutral | $5 $6 | Sep 15, 2026 |
| Guggenheim | Downgraded from Buy | Neutral | — | Aug 11, 2026 |
| Wedbush | Downgraded from Outperform | Neutral | $53 $5 | Aug 11, 2026 |
| BTIG | Downgraded from Buy | Neutral | — | Aug 10, 2026 |
| Guggenheim | Maintained | Buy | $50 $60 | Aug 7, 2026 |
| Citizens | Reiterated | Market Outperform | $63 | May 26, 2026 |
| Freedom Broker | Downgraded from Buy | Hold | $38 | May 20, 2026 |
| Stifel | Maintained | Buy | $44 $55 | May 18, 2026 |
| BTIG | Reiterated | Buy | $58 | May 13, 2026 |
| Wedbush | Initiated | Outperform | $53 | May 5, 2026 |
| Jones Trading | Maintained | Buy | $52 $63 | Apr 28, 2026 |
| BTIG | Reiterated | Buy | $58 | Apr 27, 2026 |
| Guggenheim | Maintained | Buy | $45 $50 | Mar 3, 2026 |
| BTIG | Reiterated | Buy | $58 | Mar 2, 2026 |
| Citizens | Initiated | Market Outperform | $63 | Feb 24, 2026 |
| BTIG | Reiterated | Buy | $58 | Jan 14, 2026 |
| BTIG | Maintained | Buy | $50 $58 | Jan 7, 2026 |
| LifeSci Capital | Initiated | Outperform | $60 | Dec 23, 2025 |
| RBC Capital | Downgraded from Sector Perform | Underperform | $24 | Dec 1, 2025 |
| BTIG | Initiated | Buy | $50 | Nov 19, 2025 |
| Freedom Broker | Initiated | Buy | $38 | Oct 17, 2025 |
| Jones Trading | Initiated | Buy | $46 | Sep 8, 2025 |
| Raymond James | Initiated | Strong Buy | $45 | Sep 3, 2025 |
| RBC Capital | Initiated | Sector Perform | $22 | Sep 3, 2025 |
| Stifel | Initiated | Buy | $32 | Mar 4, 2025 |
76 filings from 14 insiders · 3 buy / 9 sell over 6m
Officers and directors of SION, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P.Director; 10% owner | Sellindirect | 33.8k | $7.46 | $252k | Sep 17, 2026 |
| RA CAPITAL MANAGEMENT, L.P.Director; 10% owner | Sellindirect | 3.42M | $6.32 | $21.58M | Sep 17, 2026 |
| Fitzpatrick JenniferOfficer, CLO and Head of Program Mgmt. | OtherNon-Qualified Stock Option (right to buy) | 103.1k | — | — | Sep 17, 2026 |
| Fitzpatrick JenniferOfficer, CLO and Head of Program Mgmt. | GrantNon-Qualified Stock Option (right to buy) | 103.1k | — | — | Sep 17, 2026 |
| Fitzpatrick JenniferOfficer, CLO and Head of Program Mgmt. | Grant | 28.1k | — | — | Sep 17, 2026 |
| Fitzpatrick JenniferOfficer, CLO and Head of Program Mgmt. | Grant | 28.1k | — | — | Sep 17, 2026 |
| McKee CharlotteOfficer, CMO and Head of R&D | OtherNon-Qualified Stock Option (right to buy) | 155.7k | — | — | Sep 17, 2026 |
| McKee CharlotteOfficer, CMO and Head of R&D | GrantNon-Qualified Stock Option (right to buy) | 155.7k | — | — | Sep 17, 2026 |
| McKee CharlotteOfficer, CMO and Head of R&D | Grant | 50.0k | — | — | Sep 17, 2026 |
| McKee CharlotteOfficer, CMO and Head of R&D | Grant | 50.0k | — | — | Sep 17, 2026 |
| Ridloff ElenaOfficer, CFO and CBO | OtherNon-Qualified Stock Option (right to buy) | 165.4k | — | — | Sep 17, 2026 |
| Ridloff ElenaOfficer, CFO and CBO | GrantNon-Qualified Stock Option (right to buy) | 165.4k | — | — | Sep 17, 2026 |
| Ridloff ElenaOfficer, CFO and CBO | Grant | 47.3k | — | — | Sep 17, 2026 |
| Ridloff ElenaOfficer, CFO and CBO | Grant | 47.3k | — | — | Sep 17, 2026 |
| Cloonan MichaelDirector; Officer, President & CEO | OtherNon-Qualified Stock Option (right to buy) | 436.1k | — | — | Sep 17, 2026 |
| Cloonan MichaelDirector; Officer, President & CEO | GrantNon-Qualified Stock Option (right to buy) | 436.1k | — | — | Sep 17, 2026 |
| Cloonan MichaelDirector; Officer, President & CEO | Grant | 109.0k | — | — | Sep 17, 2026 |
| Cloonan MichaelDirector; Officer, President & CEO | Grant | 109.0k | — | — | Sep 17, 2026 |
| THOMPSON PETER ADirector | Sellindirect | 85.9k | $44.86 | $3.85M | Jul 7, 2026 |
| ORBIMED ADVISORS, L.L.C.Unknown | Sellindirect | 85.9k | $44.86 | $3.85M | Jul 7, 2026 |
No analyst notes on SION yet.
Analyst Ratings
7 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 2 | 10 | 0 | 0 | Hold2.83 |
| 1 mo ago | 0 | 2 | 10 | 0 | 0 | Hold2.83 |
| 2 mo ago | 0 | 1 | 10 | 0 | 0 | Hold2.91 |
| 3 mo ago | 1 | 8 | 1 | 0 | 1 | Buy2.27 |
Members whose judged calls on SION have played out most reliably.
No settled calls on SION yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice